咳露口服液联合氨溴索雾化吸入治疗慢阻肺急性加重期(AECOPD)80例疗效观察

Clinical observation on treating 80 cases of AECOPD by cough syrup oral liquid combined with ambroxol aerosol inhalation

目的:评价咳露口服液联合氨溴索雾化吸入治疗AECOPD患者的有效性。方法:将80例AECOPD患者随机分为治疗组和对照组。两组均给予抗感染、平喘、祛痰、吸氧等治疗。观察两组治疗前后临床疗效。结果:治疗组治疗有效率87.5%,对照组有效率62.5%,差异均有统计学意义(P<0.05)。结论:咳露口服液联合氨溴索雾化吸入治疗慢阻肺急性加重期患者是有效的,值得临床推广。

Objective： Evaluation of cough syrup oral liquid combined with Arnbroxol Aerosol Inhalation Treatment effectiveness in patients with AECOPD （Acute Exacerbations of Chronic Obstructive Pulmonary Disease）. Methods： 80 cases of AECOPD patients were randomly divided into the treated group and control group. The two groups were given anti infection, asthma, expectorant, oxygen inhalation. Two groups were observed before and after treatment. Results： The efficiency of the treated group was 87.5%, and was 62.5% of the control group, the differences were statistically significant （P〈0.05）. Conclusion： Cough syrup oral liquid combined with ambroxol atomization inhalation in the treatment of acute exacerbation of COPD patients is effective, worthy of clinical application.